European Journal of Pharmacology
October 1, 2004
Alfred Richard Green, Esther O'Shea, María Isabel Colado
The predominant severe acute adverse effect following ingestion of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) by recreational users is hyperthermia which can induce other associated clinical problems and occasionally death. There is no pharmacologically specific treatment. MDMA also induces dose-dependent hyperthermia in experimental animals. This review examines the consequences of MDMA...
Journal of Pharmacology and Experimental Therapeutics
October 2004
Douglas C. Jones, Serrine S. Lau, Terrence J. Monks
3,4-Methylenedioxyamphetamine (MDA) and 3,4-methyl-enedioxymethamphetamine (MDMA, ecstasy) are widely abused amphetamine derivatives that target the serotonin system. The serotonergic neurotoxicity of MDA and MDMA seems dependent on their systemic metabolism. 5-(Glutathion-S-yl)-alpha-methyldopamine [5-(GSyl)-alpha-MeDA] and 2,5-bis(glutathion-S-yl)-alpha-methyldopamine...
Annals of the New York Academy of Sciences
October 1, 2004
Yossef Itzhak, Karen L. Anderson, Syed F. Ali
31 citations
A bstract : It has been shown that mice deficient in neuronal nitric oxide synthase (nNOS) gene are resistant to cocaine‐induced psychomotor sensitization and methamphetamine (METH)‐induced dopaminergic neurotoxicity. The present study was undertaken to investigate the hypothesis that nNOS has a major role in dopamine (DA)‐ but not serotonin (5‐hydroxytryptamine; 5‐HT)‐mediated effects of...
Neuroscience Research Communications
September 1, 2004
Brian D. Armstrong, Elena Paik, Seririthanar Chhith et al.
AbstractTo elucidate the role of the serotonin (5‐HT)2A/2C receptors in 3,4‐methylenedioxymethamphetamine (MDMA)‐induced neurotoxicity, MDMA was administered to rats and the presence of the serotonin transporter (5‐HTT) was assessed at the protein level with immunohistochemistry (IHC), and the RNA level with a Northern blotting technique. d‐lysergic acid diethylamide (LSD) and MDL 11,939 were...
Psychopharmacology
September 2004
Niels Alting Von Geusau, Pieter Stalenhoef, Mariette Huizinga et al.
Long-term users of ecstasy have shown impaired performance on a multitude of cognitive abilities (most notably memory, attention, executive function). Research into the pattern of MDMA effects on executive functions remains fragmented, however. To determine more systematically what aspects of executive function are affected by a history of MDMA use, by using a model that divides executive...
Journal of Psychopharmacology
September 1, 2004
Verónica Sánchez, Esther O’shea, Kathryn S. Saadat et al.
66 citations
The technique of ‘binge’ dosing (several doses in one session) by recreational users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) requires evaluation in terms of its consequences on the acute hyperthermic response and long-term neurotoxicity. We examined the neurotoxic effects of this dosing schedule on 5-HT and dopamineneurones in the rat brain. When repeated (three) doses of MDMA (2,...
Journal of Forensic Sciences
September 1, 2004
Kathryn S. Kalasinsky, J. Hugel, Sj Kish
42 citations
Abstract It has recently been reported that purity of illicit tablets of ecstasy (MDMA) is now high. Our objective was to confirm whether hair of drug users, who request only ecstasy from their supplier, contains MDMA in the absence of other drugs. GC-MS analysis of scalp hair segments disclosed the presence of MDMA in 19 of 21 subjects and amphetamine/methamphetamine in eight subjects....
Neuroscience Letters
August 26, 2004
Sandra L Hrometz, Andrew Brown, David E Nichols et al.
3,4-methylenedioxymethamphetamine (MDMA, ecstasy) has been shown to induce long-term deficits in serotonergic function in animal models. Several studies have suggested that dopamine (DA) uptake into serotonin (5-HT) terminals by the 5-HT reuptake transporter (SERT) and subsequent deamination by monoamine oxidase-B (MAO-B) leads to the formation of hydrogen peroxide and may be major contributors...
Drug and Alcohol Dependence
August 16, 2004
John H. Halpern, Harrison G. Pope, Andrea R Sherwood et al.
A substantial literature suggests that users of illicit 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") display residual cognitive deficits. Most MDMA users, however, use other illicit drugs as well, so it is difficult to be certain that these deficits are due to MDMA, as opposed to other drug use or additional confounding factors. We administered a battery of neuropsychological tests to...
International Journal of Developmental Neuroscience
August 1, 2004
Charles V. Vorhees, Tracy M. Reed, Matthew R. Skelton et al.
76 citations
Abstract 3,4‐Methylenedioxymethamphetamine (MDMA) in previous experiments has been shown to induce long‐term spatial and sequential learning and memory deficits in adult offspring after exposure to the drug on postnatal (P) days 11–20, but not after exposure on P1–10. Herein we further tested for the effects of MDMA (0, 5, 10 or 20 mg/kg × 2/day) after exposure on P11–20 on reference and...